{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:42:30Z","timestamp":1772307750416,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s13181-023-00947-1","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T14:02:11Z","timestamp":1684504931000},"page":"284-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Rivastigmine Use in the Treatment of Antimuscarinic Delirium"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1119-5582","authenticated-orcid":false,"given":"Spencer C.","family":"Greene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"issue":"2","key":"947_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/15563650.2017.1342828","volume":"56","author":"AM Arens","year":"2018","unstructured":"Arens AM, Shah K, Al-Abri S, Olson KR, Kearney T. Safety and effectiveness of physostigmine: a 10-year retrospective review. Clin Toxicol. 2018;56(2):101\u20137.","journal-title":"Clin Toxicol"},{"issue":"5","key":"947_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/15563650.2020.1818768","volume":"59","author":"MW Van Kernebeek","year":"2021","unstructured":"Van Kernebeek MW, Ghesquiere M, Vanderbruggen N, Verhoeven E, Hubloue I, Crunelle CL. Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication. Clin Toxicol. 2021;59(5):447\u20138.","journal-title":"Clin Toxicol"},{"issue":"9","key":"947_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/15563650.2020.1869757","volume":"59","author":"AR Hughes","year":"2021","unstructured":"Hughes AR, Moore KK, Mah ND, Birmingham AR, Clark RK, et al. Letter in response to Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication. Clin Toxicol. 2021;59(9):855\u20136.","journal-title":"Clin Toxicol"},{"issue":"4","key":"947_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0196-0644(00)70057-6","volume":"35","author":"MJ Burns","year":"2000","unstructured":"Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med. 2000;35(4):374\u201381.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"947_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/15563650.2018.1485154","volume":"57","author":"SP Boley","year":"2019","unstructured":"Boley SP, Olives TD, Bangh SA, Fahrner S, Cole JB. Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center. Clin Toxicol. 2019;57(1):50\u20135.","journal-title":"Clin Toxicol"},{"issue":"8","key":"947_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/15563650.2020.1854281","volume":"59","author":"GS Wang","year":"2021","unstructured":"Wang GS, Baker K, Ng P, Janis GC, Leonard J, et al. A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome. Clin Toxicol. 2021;59(8):698\u2013704.","journal-title":"Clin Toxicol"},{"key":"947_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13181-014-0452-x","volume":"11","author":"JW Watkins","year":"2015","unstructured":"Watkins JW, Schwarz ES, Arroyo-Plascencia AM, Mullins ME, Toxicology Investigators Consortium investigators. The use of physostigmine by toxicologists in anticholinergic toxicity. J Med Toxicol. 2015;11:179\u201384.","journal-title":"J Med Toxicol."},{"issue":"2","key":"947_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/01.ftd.0000185770.44502.51","volume":"28","author":"NG Hunfeld","year":"2006","unstructured":"Hunfeld NG, Westerman EM, Boswijk DJ, De Haas JA, van Putten MJ, Touw DJ. Quetiapine in overdosage: a clinical and pharmacokinetic analysis of 14 cases. Ther Drug Monit. 2006;28(2):185\u20139.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"947_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/YIC.0b013e32805aedf5","volume":"22","author":"M Morgan","year":"2007","unstructured":"Morgan M, Hackett LP, Isbister GK. Olanzapine overdose: a series of analytically confirmed cases. Int Clin Psychopharmacol. 2007;22(3):183\u20136.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"947_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1067\/mem.2003.232","volume":"42","author":"AB Schneir","year":"2003","unstructured":"Schneir AB, Offerman SR, Ly BT, Davis JM, Baldwin RT, et al. Complications of diagnostic physostigmine administration to emergency department patients. Ann Emerg Med. 2003;42(1):14\u20139.","journal-title":"Ann Emerg Med"},{"key":"947_CR11","unstructured":"Medscape: Rivastigmine. Available at: https:\/\/reference.medscape.com\/drug\/exelon-oral-solution-rivastigmine-343069#10. Accessed on April 14, 2023."},{"issue":"12","key":"947_CR12","first-page":"1377","volume":"5","author":"B Winblad","year":"2008","unstructured":"Winblad B, Machado JC. Use of rivastigmine transdermal patch in the treatment of Alzheimer\u2019s disease. Expert Opin. 2008;5(12):1377\u201386.","journal-title":"Expert Opin"},{"key":"947_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s13181-010-0077-7","volume":"6","author":"C Rosenbaum","year":"2010","unstructured":"Rosenbaum C, Bird SB. Timing and frequency of physostigmine redosing for antimuscarinic toxicity. J Med Toxicol. 2010;6:386\u201392.","journal-title":"J Med Toxicol"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-023-00947-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-023-00947-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-023-00947-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T16:27:22Z","timestamp":1687796842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-023-00947-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["947"],"URL":"https:\/\/doi.org\/10.1007\/s13181-023-00947-1","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"assertion":[{"value":"25 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}